{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:54:20Z","timestamp":1761814460307,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["ZYLX201608"],"award-info":[{"award-number":["ZYLX201608"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.wneu.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:22:39Z","timestamp":1591795359000},"page":"114-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Combination of Anti\u2013Programmed Death 1 Therapy and Apatinib for a Patient with Hepatocellular Carcinoma and Brain Metastasis: Case Report and Literature Review"],"prefix":"10.1016","volume":"143","author":[{"given":"Yufei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-632X","authenticated-orcid":false,"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.06.015_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2407-12-49","article-title":"Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors","volume":"12","author":"Jiang","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.wneu.2020.06.015_bib2","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3748\/wjg.15.5481","article-title":"Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma","volume":"15","author":"Chan","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.wneu.2020.06.015_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1005716408970","article-title":"Nervous system involvement by metastatic hepatocellular carcinoma","volume":"36","author":"Kim","year":"1998","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.06.015_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-014-1546-7","article-title":"Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma","volume":"120","author":"Lim","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.06.015_bib5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1440-1746.2005.03919.x","article-title":"Clinical features of hepatocellular carcinoma with extrahepatic metastases","volume":"20","author":"Natsuizaka","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.wneu.2020.06.015_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-005-4175-3","article-title":"Brain metastases from hepatocellular carcinoma in US patients","volume":"76","author":"Seinfeld","year":"2006","journal-title":"J\u00a0Neurooncol"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2020.06.015_bib7","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1007\/BF02278115","article-title":"Intracranial metastases of hepatocellular carcinoma. CT and MRI","volume":"38","author":"Murakami","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1016\/j.wneu.2020.06.015_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/SLA.0b013e31820d944f","article-title":"Hepatocellular carcinoma: current management and perspectives for the future","volume":"253","author":"Rahbari","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.wneu.2020.06.015_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-008-9713-3","article-title":"Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC","volume":"91","author":"Choi","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.06.015_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.surneu.2003.10.002","article-title":"Intracranial metastasis of hepatocellular carcinoma: review of 45 cases","volume":"62","author":"Chang","year":"2004","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2020.06.015_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3340\/jkns.2010.47.5.325","article-title":"Little response of cerebral metastasis from hepatocellular carcinoma to any treatments","volume":"47","author":"Han","year":"2010","journal-title":"J\u00a0Korean Neurosurg Soc"},{"key":"10.1016\/j.wneu.2020.06.015_bib12","first-page":"331","article-title":"Excellent response to anti-PD-1 therapy in a patient with hepatocellular carcinoma case report and review of literature","volume":"23","author":"Mamdani","year":"2017","journal-title":"Discov Med"},{"key":"10.1016\/j.wneu.2020.06.015_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12094-018-1975-4","article-title":"Programmed cell death protein-1 (PD-1)\/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives","volume":"21","author":"Mocan","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.wneu.2020.06.015_bib14","first-page":"3347","article-title":"Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma","volume":"41","author":"Yu","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.wneu.2020.06.015_bib15","first-page":"466","article-title":"Present treatment situation of hepatocellular carcinoma with extrahepatic metastasis [in Chinese]","volume":"57","author":"Mao","year":"2019","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.wneu.2020.06.015_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10147-019-01407-z","article-title":"Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma","volume":"24","author":"Nam","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.wneu.2020.06.015_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40265-019-01076-2","article-title":"Toripalimab: first global approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.wneu.2020.06.015_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2018.02.014","article-title":"Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells","volume":"1864","author":"Li","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.wneu.2020.06.015_bib19","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.2147\/OTT.S161023","article-title":"Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.wneu.2020.06.015_bib20","doi-asserted-by":"crossref","first-page":"e11214","DOI":"10.1097\/MD.0000000000011214","article-title":"The excellent antitumor effect of apatinib alone as second-line therapy in a patient with sorafenib-refractory hepatocellular carcinoma: a case report","volume":"97","author":"Zhu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2020.06.015_bib21","doi-asserted-by":"crossref","first-page":"e9704","DOI":"10.1097\/MD.0000000000009704","article-title":"Efficacy and safety of apatinib in patients with intermediate\/advanced hepatocellular carcinoma: a prospective observation study","volume":"97","author":"Yu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2020.06.015_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4103\/jcrt.JCRT_400_19","article-title":"Apatinib for hepatocellular carcinoma","volume":"15","author":"Ni","year":"2019","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.wneu.2020.06.015_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/15384047.2017.1323589","article-title":"Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: a single-center randomized controlled trial","volume":"18","author":"Lu","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.wneu.2020.06.015_bib24","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.2147\/OTT.S146051","article-title":"Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report","volume":"10","author":"Ma","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.wneu.2020.06.015_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1158\/1078-0432.CCR-18-2484","article-title":"Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer: an open-label, dose escalation and expansion study","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020312730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020312730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:51:11Z","timestamp":1761814271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020312730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":25,"alternative-id":["S1878875020312730"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.06.015","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Anti\u2013Programmed Death 1 Therapy and Apatinib for a Patient with Hepatocellular Carcinoma and Brain Metastasis: Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}